Ferrão Diana, Silva Clara, Nogueira-Silva Luis, Almeida Jorge
Internal Medicine, Centro Hospitalar Universitário de São João, Porto, PRT.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, University of Porto, Porto, PRT.
Cureus. 2022 Nov 21;14(11):e31744. doi: 10.7759/cureus.31744. eCollection 2022 Nov.
Hemolytic anemia is an increasingly recognized complication of cytomegalovirus (CMV) infection in immunocompetent patients. Although it is thought to be immune-mediated, other mechanisms have been proposed. The decision to treat is controversial but it may include antiviral and immunosuppressive therapy. We report a case of CMV-induced hemolytic anemia in a previously healthy 55-year-old woman. The patient presented with asthenia and choluria, and laboratory tests showed severe anemia with hyperbilirubinemia and elevated lactate dehydrogenase. A diagnosis of hemolytic anemia was made. Structural, enzymatic, toxic, pharmacological, and neoplastic causes were excluded. The CMV immunoglobulin M was positive, with a negative direct antiglobulin test. The patient had an improvement in clinical and laboratory status without any treatment, and two months later she had a full recovery of the anemia. This case illustrates that CMV infection might be associated with severe organ damage in immunocompetent patients but has an overall good prognosis without any directed treatment.
溶血性贫血是免疫功能正常患者中越来越被认识到的巨细胞病毒(CMV)感染并发症。尽管认为其是免疫介导的,但也提出了其他机制。治疗决策存在争议,但可能包括抗病毒和免疫抑制治疗。我们报告一例55岁既往健康女性发生的CMV诱导的溶血性贫血。患者表现为乏力和胆汁尿,实验室检查显示严重贫血伴高胆红素血症和乳酸脱氢酶升高。诊断为溶血性贫血。排除了结构性、酶性、毒性、药物性和肿瘤性病因。CMV免疫球蛋白M阳性,直接抗球蛋白试验阴性。患者未经任何治疗临床和实验室状态有所改善,两个月后贫血完全恢复。该病例说明CMV感染在免疫功能正常患者中可能与严重器官损害相关,但未经任何针对性治疗总体预后良好。